Abstract
There are two types of tyrosinemia: tyrosinemia type 1 due to fumarylacetoacetase deficiency which is a hepatorenal form without skin abnormalities, and tyrosinemia type II or Richner—Hanhart Syndrome due to hepatic cytosolic aminotransferase deficiency, which is the oculocutaneous form of the disease we will discuss in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Hemidan AL, al-Hazzaa SA (1995) Richner-Hanhart syndrome (Tyrosinemia type II). Case report and literature review. Ophthal Genet 16: 21–26.
Barr DGD, Kirk JM, Laing SC (1991) Outcome of tyrosinaemia type II. Arch Dis Child 66: 1249–1250.
Barton DE, Yang-Feng TL, Francke V (1986) The human tyrosine aminotransferase gene mapped to the long arm of chromosome 16 (region 16q22-q24) by somatic cell hybrid analysis and in situ hybridization. Hum Genet 72: 221.
Bonhert A, Anton-Lamprecht I (1982) Richner-Hanhart’s syndrome: ultrastructural abnormalities of epidermal keratinization indicating a causal relationship to high intracellular tyrosine levels. J Invest Dermatol 79: 68–74.
Burns PR (1972) The tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers. Am J Opthalmol 73: 400.
el-Shoura SM, Tallab TM (1997) Richner-Hanhart’s syndrome: new ultrastructural observations on skin lesions of two cases. Ultrastruct Pathol 21: 51–56.
Fraser NG, MacDonald J, Griffiths WAD, McPhie JL (1987) Tyrosinaemia type II (Richner-Hanhart syndrome) report of two cases treated with etretinate. Clin Exp Dermatol 12: 440–443.
Gipson IK, Burns RP, Wolfe-Lande JD (1975) Crystals in corneal epithelial lesions of tyrosine fed rats. Invest Ophthalmol 14: 937.
Goldsmith LA, Kang E, Bienfang DC, Jimbow K, Gerald R, Baden HP (1973) Tyrosinaemia with plantar and palmar keratosis and keratitis. J Pediatr 83: 798–805.
Goldsmith LA (1975) Hemolysis and lysosomal activation by solid state tyrosine. Biochem Biophys Res Commun 64: 558.
Goldsmith LA (1976) Haemolysis induced by tyrosine crystals. Modifiers and inhibitors. Biochem J 158: 17.
Goldsmith LA (1978a) Molecular biology and molecular pathology of a newly described molecular disease-tyrosinemia II (the Richner-Hanhart syndrome). Exp Cell Biol 46: 96.
Goldsmith LA (1978b) Tyrosine-induced skin disease. Br J Dermatol 98: 119.
Goldsmith LA, Thorpe J, Roe CR (1979) Hepatic enzymes of tyrosine metabolism in tyrosinaemia II. J Invest Dermatol 73: 530–532.
Goldsmith LA (1985) Tyrosinemia II. A large North Carolina kindred. Arch Intern Med 145: 1697–1700.
Goldsmith LA, Laberge C (2005) Tyrosinemia and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) The metabolic basis of inherited disease. 10th ed. New York McGraw-Hill, pp. 547–562.
Hanhart E (1947) Neue Sonderformen von keratosis palmoplantaris, u. a. eine regelmässig-dominate Form mit systematisierten Lipomen, ferner zwei einfach rezessive, mit Schwachsinn und mit Hornhautveränderungen des Auges (Ektodermalsyndrom). Dermatologica 94: 286–308.
Huhn R, Stoermer H, Klingele B et al. (1998) Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II. Hum Genet 102: 305–313.
Hunziker N (1980) Richner-Hanhart syndrome and tyrosinemia type II. Dermatologica 160: 180–189.
Irons M, Harvey LL (1986) Metabolic syndromes with dermatological manifestations. Clin Rev Allergy 4: 101–124.
Kato M, Suzuki N, Koeda T (1993) A case of tyrosinemia type II with convulsion and EEG abnormality. No To Hattatsu 25: 558–562.
Larregue M, de Giacomoni PH, Bressieux JM, Odievre M (1979) Syndrome de Richner-Hannart ou tyrosinose oculo-cutanee. Ann Dermatol Venéréol 106: 53–62.
Macsai MS, Schwartz TL, Hinkle D, Hummel MB, Mulhern MG, Rootman D (2001) Tyrosinemia type II: nine cases of ocular signs and symptoms. Am J Ophthalmol 132: 522–527
Natt E, Kao PT, Rettenmeier R, Scherer G (1986) Assignment of the human tyrosine aminotransferase gene to chromosome 16. Hum Genet 72: 225.
Pelet B, Anteneri L, Faggioni R, Spahr A, Gautier A (1979) Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia). Helv Paediatr Acta 34: 177.
Prader A (1971) Eulogy. Prof Ernst Hanhart 80th year. Schweizerische medizinische Wochenschrift 101/11: 402.
Rehak A, Selim MM, Yadau G (1981) Richner-Hanhart syndrome (Tyrosinemia II). Br J Dermatol 104: 469–475.
Richner H (1938) Hornhautaffektionen bei keratoderma palmare et plantare hereditarium. Klin Monatsbl Augenheilkd 100: 580–588.
Shimizu N, Ito M, Ito K, Nakamura A, Sato Y, Maruyama T (1990) Richner-Hanhart’s syndrome: electron microscopic study of the skin lesions. Arch Dermatol 126: 1342.
Vererbung der Netzhautablösung. Würzburg (1936) Offprint from Graefes Archiv für Ophthalmologie 135: 49–66 [Medical thesis Zürich with curriculum vitae]
Waardenburg PJ, Franceschetti A, Klein D (1961) Genetics and ophthalmology. Springfield III: Charles C Thomas Publishers, pp. 515–517
Westphal EM, Natt E, Grimm T, Odievre M, Scherer G (1988) The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II. Hum Genet 79: 260–264.
Who named it? (2006) A dictionary of medical biographies. http://www.whonamedit.com
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag/Wien
About this chapter
Cite this chapter
Orozco-Covarrubias, L., Saez-De-Ocariz, M., Durán-McKinster, C., Ruiz-Maldonado, R. (2008). Richner-Hanhart Syndrome (Tyrosine Transaminase Deficiency). In: Ruggieri, M., Pascual-Castroviejo, I., Di Rocco, C. (eds) Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes. Springer, Vienna. https://doi.org/10.1007/978-3-211-69500-5_42
Download citation
DOI: https://doi.org/10.1007/978-3-211-69500-5_42
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-21396-4
Online ISBN: 978-3-211-69500-5
eBook Packages: MedicineMedicine (R0)